Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: November 1, 1999
Last updated: June 20, 2013
Last verified: May 2000
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2004
  Estimated Primary Completion Date: No date given